Credo Technology Group Holding Ltd shares have been dropping, down 30%+ from recent highs. Learn more about CRDO stock here.
Palantir is a Strong Buy ahead of Q2 earnings as revenue and profits surge, commercial growth accelerates, and valuation ...
Search/Cloud growth and +30% operating income, but FCF turns negative as capex surges. Click here to read my latest analysis.
British American Tobacco is rated a Buy; transitioning into next-generation nicotine products is key. Read more on BTI stock ...
Key 2026 catalysts include the trastuzumab pamirtecan BLA filing, pivotal Phase 3 oncology readouts, and a binary EPO patent ...
Qure N.V. downgraded to Hold as AMT-130 faces FDA uncertainty; BLA targeted Q3 2026 with key data due Sept 2026. Click for ...
BTSG stock plunged 18% after Q2 earnings. See BrightSpring’s EPS/revenue beat, raised 2026 guidance, valuation concerns and ...
Tilray (TLRY) stock jumps after Q4 earnings: revenue beat, BrewDog-driven beverage growth, and FY2027 EBITDA guidance.
Accenture (ACN) at 12x FY26 earnings after a 40% drop offers 4% yield. Read more about the potential opportunity and risks in ...
Next week’s stock market catalysts: key earnings, IPOs, dividends, Fed data, and OPEC+ moves—plus volatility/RSI names to ...
WisdomTree Cloud Computing Fund ETF is currently fairly valued, making it suitable for hedging against undervalued software ...
Adaptive Biotechnologies (ADPT) pivots to pure-play MRD diagnostics as clonoSEQ adoption, margins & backlog surge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results